Skip to main content

Find Clinical Trials

Home
Conditions
Pulmonary Tuberculosis

Clinical trial condition

Pulmonary Tuberculosis

Explore clinical trials studying Pulmonary Tuberculosis. Study availability and eligibility vary by location and protocol.

78 public trials 10 recruiting studies

Refine in advanced search Browse all conditions

Pulmonary Tuberculosis trial results

Completed

PA-824-CL-007: Phase IIa Evaluation of Early Bactericidal Activity in Pulmonary Tuberculosis

NCT00567840

Conditions: Actinomycetales Infections, Bacterial Infections, Bacterial Infections and Mycoses, +9 more
Locations: Tiervlei Trials Center, Stellenbosch University Cape Town, Cape Province, South Africa

University of Cape Town Lung Institute Cape Town, Cape Province, South Africa

View Trial Details

Completed

Evaluation of Early Bactericidal Activity in Pulmonary Tuberculosis (TMC207-CL001)

NCT01215110

Conditions: Actinomycetales Infections, Bacterial Infections, Bacterial Infections and Mycoses, +9 more
Locations: Karl Bremer Hospital Belville, Cape Town, South Africa

View Trial Details

Completed

Controlled Comparison of Two Moxifloxacin Containing Treatment Shortening Regimens in Pulmonary Tuberculosis

NCT00864383

Conditions: Actinomycetales Infections, Bacterial Infections, Bacterial Infections and Mycoses, +9 more
Locations: Beijing Tuberculosis and Thoracic Tumor Research Institute Beijing, China

Shanghai Pulmonary Hospital Shanghai, China

TB Institute Tianjin, China

Nirmal Kumar Jain Jaipur, Rajasthan, India

View all 47 locations

View Trial Details

Completed

Evaluation of Early Bactericidal Activity in Pulmonary Tuberculosis With(J-M-Pa-Z) (NC-001)

NCT01215851

Conditions: Actinomycetales Infections, Bacterial Infections, Bacterial Infections and Mycoses, +9 more
Locations: Centre for Tuberculosis Research Innovation, UCT Lung Institute Cape Town, South Africa

Task Applied Science, Karl Bremer Hospital Cape Town, South Africa

View Trial Details

Completed

Evaluation of Early Bactericidal Activity in Pulmonary Tuberculosis With Clofazimine (C)-TMC207 (J)-PA-824 (Pa)-Pyrazinamide (Z)

NCT01691534

Conditions: Actinomycetales Infections, Bacterial Infections, Bacterial Infections and Mycoses, +9 more
Locations: Centre for Tuberculosis Research Innovation, UCT Lung Institute Cape Town, South Africa

Task Applied Science, Karl Bremer Hospita Cape Town, South Africa

View Trial Details

Completed

Efficacy and Safety of Qinbudan as an Adjunct Therapy for Retreatment Pulmonary Tuberculosis

NCT02313610

Conditions: Actinomycetales Infections, Bacterial Infections, Bacterial Infections and Mycoses, +9 more
Locations: Hebei provincial chest hospital Shijiazhuang, Hebei, China

The first affiliated hospital of Xinxiang Medical University Xinxiang, Henan, China

Wuhan tuberculosis dispensary Wuhan, Hubei, China

Jiangxi provincial chest hospital Nanchang, Jiangxi, China

View Trial Details

Completed

Could the Stroke Volume Variation Predict a Fluid Responsiveness in Thoracotomy?

NCT02331056

Conditions: Actinomycetales Infections, Bacterial Infections, Bacterial Infections and Mycoses, +15 more
Locations: Samsung medical center Seoul, South Korea

View Trial Details

Completed

Prospective Assessment of TBDx Feasibility

NCT02912832

Conditions: Actinomycetales Infections, Bacterial Infections, Bacterial Infections and Mycoses, +12 more
Locations: Instituto de Medicina Tropical Alexander von Humboldt - Universidad Peruana Cayetano Heredia Lima, Peru

Pham Ngoc Thach Hospital Ho Chi Minh City, Vietnam

View Trial Details

Completed

Intervention in the Management of Post-high Tuberculosis Hospital Through Educational Strategy and Oversight Distance

NCT02558842

Conditions: Actinomycetales Infections, Bacterial Infections, Bacterial Infections and Mycoses, +11 more
Locations: Alice Mânica Müller Porto Alegre, Rio Grande do Sul, Brazil

View Trial Details

Completed

Linezolid to Treat Extensively-Drug Resistant Tuberculosis

NCT00727844

Conditions: Actinomycetales Infections, Bacterial Infections, Bacterial Infections and Mycoses, +13 more
Locations: National Masan Tuberculosis Hospital Changwon, South Korea

National Medical Center Seoul, South Korea

View Trial Details